P. Koszałka

发表

Antitumor Activity of Antimicrobial Peptides against U937 Histiocytic Cell Line

W. Kamysz, Magdalena Wejda, P. Koszałka, 2022 .

In Silico Designed Gain-of-Function Variants of Complement C2 Support Cytocidal Activity of Anticancer Monoclonal Antibodies

J. Zaucha, M. Okrój, A. Felberg, 2022, Cancers.

An unusual nicotinamide derivative, 4-pyridone-3-carboxamide ribonucleoside (4PYR), is a novel endothelial toxin and oncometabolite

E. Slominska, R. Smolenski, P. Koszałka, 2021, Experimental & Molecular Medicine.

4-Pyridone-3-carboxamide-1-β-D-ribonucleoside (4PYR)—A Novel Oncometabolite Modulating Cancer-Endothelial Interactions in Breast Cancer Metastasis

E. Slominska, R. Smolenski, J. Wietrzyk, 2022, International journal of molecular sciences.

Anti-tumor action of tumor necrosis factor against Bomirski Ab melanoma in hamsters

E. Szmit, A. Myśliwski, P. Koszałka, 2007, Archivum Immunologiae et Therapiae Experimentalis.

Wacław Szybalski's contribution to immunotherapy: HGPRT mutation & HAT selection as first steps to gene therapy and hybrid techniques in mammalian cells.

P. Koszałka, J. Bigda, 2013, Gene.

The Cooperative Anti-Neoplastic Activity of Polyphenolic Phytochemicals on Human T-Cell Acute Lymphoblastic Leukemia Cell Line MOLT-4 In Vitro

T. Bączek, P. Koszałka, M. Niedźwiecki, 2022, International journal of molecular sciences.

Inhibition of LPS-stimulated ecto-adenosine deaminase attenuates endothelial cell activation.

Rafał Bartoszewski, E. Slominska, R. Smolenski, 2019, Journal of molecular and cellular cardiology.

Adenosine deaminase inhibition suppresses progression of 4T1 murine breast cancer by adenosine receptor‐dependent mechanisms

E. Slominska, R. Smolenski, P. Koszałka, 2018, Journal of cellular and molecular medicine.

Impaired l-arginine metabolism marks endothelial dysfunction in CD73-deficient mice

E. Slominska, R. Smolenski, P. Koszałka, 2019, Molecular and Cellular Biochemistry.

Specific Activation of A3, A2A and A1 Adenosine Receptors in CD73-Knockout Mice Affects B16F10 Melanoma Growth, Neovascularization, Angiogenesis and Macrophage Infiltration

M. Stanisławowski, A. Składanowski, P. Koszałka, 2016, PloS one.

Chemometric Evaluation of Urinary Steroid Hormone Levels as Potential Biomarkers of Neuroendocrine Tumors

T. Bączek, A. Plenis, Natalia Miękus, 2013, Molecules.

Defective apoptosis of U937 cells induced by benzyl isothiocyanate (BITC).

P. Koszałka, J. Bigda, Grzegorz Stasiłojć, 2019, Acta biochimica Polonica.

Inhibition of CD73 stimulates the migration and invasion of B16F10 melanoma cells in vitro, but results in impaired angiogenesis and reduced melanoma growth in vivo.

A. Składanowski, Anna Pryszlak, P. Koszałka, 2014, Oncology reports.

Distribution of ectonucleotidases in the rodent brain revisited

J. Schrader, S. Robson, D. Langer, 2008, Cell and Tissue Research.

The effects of pro- and anti-atherosclerotic factors on intracellular nucleotide concentration in murine endothelial cells

E. Slominska, R. Smolenski, P. Koszałka, 2018, Nucleosides, nucleotides & nucleic acids.

Adenosine produced via the CD73/ecto-5′-nucleotidase pathway has no impact on erythropoietin production but is associated with reduced kidney weight

J. Schrader, Z. Ding, A. Gödecke, 2006, Pflügers Archiv.

Targeted Disruption of cd73/Ecto-5′-Nucleotidase Alters Thromboregulation and Augments Vascular Inflammatory Response

K. Ley, Michael L. Smith, A. Zernecke, 2004, Circulation research.

CD73 on B16F10 melanoma cells in CD73-deficient mice promotes tumor growth, angiogenesis, neovascularization, macrophage infiltration and metastasis.

P. Wierzbicki, M. Stanisławowski, A. Składanowski, 2015, The international journal of biochemistry & cell biology.

U937 variant cells as a model of apoptosis without cell disintegration

J. O'connor, E. Slominska, J. Świerczyński, 2013, Cellular & Molecular Biology Letters.

Gel electrophoretic separation of proteins from cultured neuroendocrine tumor cell lines.

T. Bączek, A. Plenis, Natalia Miękus, 2015, Molecular medicine reports.

Targeted Disruption of cd73 /Ecto-5 (cid:1) -Nucleotidase Alters Thromboregulation and Augments Vascular Inflammatory Response Integrative Physiology

K. Ley, Michael L. Smith, A. Zernecke, 2004 .

Differences in Extracellular NAD+ and NMN Metabolism on the Surface of Vascular Endothelial Cells

E. Slominska, R. Smolenski, P. Koszałka, 2022, Biology.

The effect of angiogenesis inhibitor TNP-470 on the blood vessels of the lungs, kidneys and livers of treated hamsters.

E. Szmit, A. Myśliwski, P. Koszałka, 2004, Folia morphologica.

Impaired l-arginine metabolism marks endothelial dysfunction in CD73-deficient mice

E. Slominska, R. Smolenski, P. Koszałka, 2019, Molecular and Cellular Biochemistry.

Drugs targeting adenosine signaling pathways: A current view.

C. Cicala, P. Koszałka, B. Kutryb-Zajac, 2023, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

DEPARTMENT OF CELL BIOLOGY

M. Okrój, P. Koszałka, J. Bigda, 2004 .

Inhibition of CD73 stimulates the migration and invasion of B16F10 melanoma cells in vitro, but results in impaired angiogenesis and reduced melanoma growth in vivo.

A. Składanowski, Anna Pryszlak, P. Koszałka, 2014, Oncology reports.

U937 variant cells as a model of apoptosis without cell disintegration

J. O'connor, E. Slominska, P. Koszałka, 2013, Cellular & Molecular Biology Letters.

Antitumor Activity of Antimicrobial Peptides against U937 Histiocytic Cell Line

W. Kamysz, P. Koszałka, E. Kamysz, 2022 .

Complete remission of Bomirski Ab amelanotic melanoma in hamsters treated with the angiogenesis inhibitor TNP-470.

E. Szmit, A. Myśliwski, P. Koszałka, 2002, Neoplasma.